BDSX News and Press, Biodesix Inc. From 05/13/25

2025-05-13 20:22:56 ET More on Biodesix Biodesix, Inc. (BDSX) Q1 2025 Earnings Call Transcript Biodesix, Inc. (BDSX) Q4 2024 Earnings Call Transcript Seeking Alpha’s Quant Rating on Biodesix Historical earnings data for Biodesix Financial infor...

2025-05-13 20:22:08 ET Biodesix, Inc. (BDSX) Q1 2025 Results Conference Call May 13, 2025 04:30 PM ET Company Participants Chris Brinzey - Investor Relations Scott Hutton - Chief Executive Officer Robin Harper Cowie - Chief Financial Officer Conference Call...

Total Q1 2025 Revenue of $18.0 million, an increase of 21% over Q1 2024; Gross margins of 79.4% for Q1 2025 ; Q1 2025 Net loss improved by 18% compared to Q1 2024; Updated 2025 Revenue Guidance to a range of $80-85 million; Conference Call and Webcast Today at ...

urban-gro Inc. (UGRO) is expected to report for quarter end 2025-03-31 Karman Holdings Inc. (KRMN) is expected to report $0.02 for Q1 2025 PyroGenesis Inc Com (PYRGF) is expected to report for quarter end 2025-03-31 GeoVax Labs Inc. (GOVX) is expected to report $-0.59 for Q1 2025 ...

2025-05-12 18:48:12 ET Biodesix, Inc. (BDSX) - This analysis reviews how the stock price reacted during the last 12 earnings periods. The average open to high on the day of earnings was 6.52%. The average open to low on the day of earnings was -11.33%. The average open to close ...

2025-05-12 18:43:11 ET Biodesix, Inc. (BDSX) - Following Earnings Price Analysis was done using last 12 quarters historical earnings. Opening Gap Moves The historical opening gap move in BDSX stock price following earnings has averaged ±5.42% , with a median of 4.27%. The s...

LOUISVILLE, Colo., April 29, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, today announced that it will release financial results for the first quarter ended March 31, 2025 after the close of trading on Tuesday, May 13. Biodesix management wil...

LOUISVILLE, Colo. and HERCULES, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc (Nasdaq: BDSX), a leading diagnostics solutions company, and Bio-Rad Laboratories (NYSE: BIO), a global leader in life science research and diagnostics products, contributed to new research findings from Fr...

2025-03-03 20:06:21 ET Biodesix, Inc. (BDSX) Q4 2024 Earnings Conference Call March 3, 2025, 4:30 PM ET Company Participants Chris Brinzey - Investor Relations Scott Hutton - Chief Executive Officer Robin Harper Cowie - Chief Financial Officer Conference Ca...

2025-03-03 16:06:30 ET More on Biodesix Seeking Alpha’s Quant Rating on Biodesix Historical earnings data for Biodesix Financial information for Biodesix Read the full article on Seeking Alpha For further details see: Biodesix GAAP EPS of -...